Matches in Wikidata for { <http://www.wikidata.org/entity/Q61637057> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q61637057 description "article scientifique publié en 2004" @default.
- Q61637057 description "article" @default.
- Q61637057 description "im Februar 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61637057 description "wetenschappelijk artikel" @default.
- Q61637057 description "наукова стаття, опублікована в лютому 2005" @default.
- Q61637057 name "Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of Highly Active Antiretroviral Therapy: From the AIDS Malignancy Consortium and IM862 Study Team" @default.
- Q61637057 name "Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of Highly Active Antiretroviral Therapy: From the AIDS Malignancy Consortium and IM862 Study Team" @default.
- Q61637057 type Item @default.
- Q61637057 label "Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of Highly Active Antiretroviral Therapy: From the AIDS Malignancy Consortium and IM862 Study Team" @default.
- Q61637057 label "Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of Highly Active Antiretroviral Therapy: From the AIDS Malignancy Consortium and IM862 Study Team" @default.
- Q61637057 prefLabel "Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of Highly Active Antiretroviral Therapy: From the AIDS Malignancy Consortium and IM862 Study Team" @default.
- Q61637057 prefLabel "Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of Highly Active Antiretroviral Therapy: From the AIDS Malignancy Consortium and IM862 Study Team" @default.
- Q61637057 P1433 Q61637057-A293703D-09DA-4BA0-B23A-1E46D5D34E09 @default.
- Q61637057 P1476 Q61637057-1103656E-6797-4BDE-81A4-024709B58972 @default.
- Q61637057 P2093 Q61637057-42CC876E-CBE5-4634-8CF9-35AA311F6F61 @default.
- Q61637057 P2093 Q61637057-BD9CCD2A-E0C8-4A89-93BA-8F0E3A395F4F @default.
- Q61637057 P2093 Q61637057-D78CA5B4-F691-45AA-97D1-2A24C48124CD @default.
- Q61637057 P2093 Q61637057-E35F3561-CD0A-4056-85C4-031F0721CF24 @default.
- Q61637057 P2093 Q61637057-ED53C654-C91F-4BAB-B219-27927C6DB27B @default.
- Q61637057 P304 Q61637057-23743D38-5421-428D-9B63-8319003D489F @default.
- Q61637057 P31 Q61637057-DC282DCC-ED64-4B34-B27D-D11A3229E49D @default.
- Q61637057 P356 Q61637057-9FAC479D-281D-4085-8913-368391CC5826 @default.
- Q61637057 P407 Q61637057-E6DD78C8-24C4-4E8E-AB82-4CD581A8F393 @default.
- Q61637057 P433 Q61637057-8C0A6023-319B-4A24-BAC8-FB94B37C21B6 @default.
- Q61637057 P478 Q61637057-65D62C2F-BCC7-4176-B315-D0C971E24244 @default.
- Q61637057 P50 Q61637057-600C26CC-99FA-47A9-AB86-E71CF0C72173 @default.
- Q61637057 P50 Q61637057-862D3535-CBAB-4CA5-8821-30D142F7AAF1 @default.
- Q61637057 P50 Q61637057-F2ECAA25-7501-48CF-8C69-7498791FCEB4 @default.
- Q61637057 P577 Q61637057-60358CCE-BAC5-452F-9025-55D73CD02DE2 @default.
- Q61637057 P698 Q61637057-3BEC0C6B-3507-424C-A1D4-0FDFE9ACEA0D @default.
- Q61637057 P921 Q61637057-23BCF2D0-4F53-444E-AE49-8220E558EE26 @default.
- Q61637057 P921 Q61637057-B29219EE-4790-484D-8545-2A38E4CB6DA2 @default.
- Q61637057 P356 JCO.2005.11.043 @default.
- Q61637057 P698 15598977 @default.
- Q61637057 P1433 Q400292 @default.
- Q61637057 P1476 "Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team" @default.
- Q61637057 P2093 "Anil Tulpule" @default.
- Q61637057 P2093 "Bruce J Dezube" @default.
- Q61637057 P2093 "David Aboulafia" @default.
- Q61637057 P2093 "Jeannette Lee" @default.
- Q61637057 P2093 "Parkash Gill" @default.
- Q61637057 P304 "990-998" @default.
- Q61637057 P31 Q13442814 @default.
- Q61637057 P356 "10.1200/JCO.2005.11.043" @default.
- Q61637057 P407 Q1860 @default.
- Q61637057 P433 "5" @default.
- Q61637057 P478 "23" @default.
- Q61637057 P50 Q37385108 @default.
- Q61637057 P50 Q72252101 @default.
- Q61637057 P50 Q88652265 @default.
- Q61637057 P577 "2004-12-14T00:00:00Z" @default.
- Q61637057 P698 "15598977" @default.
- Q61637057 P921 Q42824827 @default.
- Q61637057 P921 Q574834 @default.